Showing results (211-220 of 555) with videos related to
Sort By:
Pageof 56
Journal of Neurochemistry|January 1, 1988
Tyrosine hydroxylase activity in caudate nucleus from Parkinson's disease: effects of iron and phosphorylating agentsW D Rausch, Y Hirata, T Nagatsu, et al.Journal of Neurochemistry|March 1, 1991
Selective increase of iron in substantia nigra zona compacta of parkinsonian brainsE Sofic, W Paulus, K Jellinger, et al.Journal of Neural Transmission|January 1, 1978
Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administrationG P Reynolds, P Riederer, M Sandler, et al.Journal of Neurochemistry|May 29, 1998
In vitro studies of ferritin iron release and neurotoxicityK L Double, M Maywald, M Schmittel, et al.Neurochemistry International|March 1, 1993
The thiobarbituric acid assay reflects susceptibility to oxygen induced lipid peroxidation in vitro rather than levels of lipid hydroperoxides in vivo: a methodological approachM E Götz, A Dirr, A Freyberger, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|October 12, 2021
Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson's diseaseP Riederer, C Monoranu, S Strobel, et al.Journal of Neural Transmission. Supplementum|October 5, 2006
The effect of neuromelanin on the proteasome activity in human dopaminergic SH-SY5Y cellsW Maruyama, M Shamoto-Nagai, Y Akao, et al.Life Sciences|January 1, 1989
Effect of antemortem and postmortem factors on [3H]MK-801 binding in the human brain: transient elevation during early childhoodJ Kornhuber, F Mack-Burkhardt, C Konradi, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|November 6, 2017
Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT3) levels in post-mortem brain tissue from patients with depression compared to healthy individuals - a proof of concept studyA Sheldrick, S Camara, M Ilieva, et al.Journal of Neural Transmission. Supplementum|January 1, 1978
CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathiesP Riederer, W D Rausch, W Birkmayer, et al.Pageof 56